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Brucellosis 
Aetiology and epidemiology 
Brucellosis (also known as undulant fever , 
Mediterranean fever, Malta fever), is a specific 
disease of animals which is occasionally trans-
mitted to man, by direct or indirect contact. It is 
caused by small, Gram-negative, non-spore-
forming coccobacilli of the genus Brucella . 
There are three important pathogenic species. 
• Brucella melitensis, the most virulent and 
invasive species, usually affects goats, and occa-
sionally sheep; it is mainly transmitted to man 
through consumption of raw (unboiled, unpas-
teurized) milk, or milk products from infected 
animals. 
• Brucella abortus is less virulent and is prim-
arily a disease of cattle, in which it causes 
contagious abortion. 
• Brucella suis is of intermediate virulence and 
chiefly affects pigs. 
B. abortus and B. suis are usually transmitted 
to man by direct contact with raw meat or 
vaginal discharges from infected animals. Infec-
tion is most common in farmers, meat-handlers 
(e.g. abbatoir workers, butchers, meat-packers, 
tanners), and veterinary surgeons. Hence, bru-
cellosis is considered an occupational disease. 
Brucellosis is distributed worldwide and is 
endemic wherever cattle, pigs, goats and sheep 
are raised in large numbers . Transmission is 
usually from animals to man, and only in 
exceptional circumstances from man-to-man 
(e.g. unsuspected brucellosis in blood donors 
may lead to infection of recipients, or there may 
be contamination of food with urine); occasion-
ally, brucellosis is acquired directly from COIl-
taminated laboratory material. 
Pathology 
The portal of entry for brucella organisms is 
usually the upper digestive tract (buccopharyn-
geallymphoid tissue) or through cuts and abra-
sions in the skin, and seldom via the conjunctiva 
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or the respiratory tract. The organisms reach the 
regional lymph nodes by lymphatic spread. 
There they mUltiply and eventually invade the 
bloodstream, causing bacteraemia. They are 
then taken up by macro phages, in which they 
may multiply, and subsequently localize in the 
endothelial cells of the bone marrow, lymph 
nodes, spleen and liver, and also in other struc-
tures, such as bone and meninges (intracellular 
parasitization). Once localized, they induce a 
characteristic (but nonspecific) cellular reaction, 
a granuloma, consisting oflymphocytes, plasma 
cells, endothelial cells and, usually, giant cells as 
in tuberculosis, syphilis or sarcoidosis. 
The subsequent histopathology depends on 
the nature and extent of the immunological 
reaction of the host and the degree of hypersen-
sitivity to brucella antigen. Often, after a varia-
ble period, the granulomas regress; but in other 
cases necrosis is extensive and a 'cold abscess' 
forms, from which an orange-yellow pseudo-
purulent material containing brucellae is 
eventually discharged. In other instances, prolif-
erative changes occur with reticuloendothelial 
hyperplasia, hyperaemia, increased tissue infil-
tration, and diffuse granuloma formation. 
Thus, brucellae may remain latent for some 
time (weeks, months or even years), before 
eventually being destroyed or causing overt 
disease. 
Clinical features 
Several patterns of disease are recognized. 
Acute brucellosis: after an incubation period, 
generally of 1-3 weeks, the onset is usually 
abrupt, and often associated with one or more 
of the symptoms and signs given in Figure I. 
In about 10% of cases (especially infections 
with B. melitensis), the patient is markedly 
toxic, with high continued fever and serious 
visceral complications (notably bronchopneu-
monia, toxic myocarditis and nephritis) and the 
mortality rate is high if specific therapy is not 
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Common manifestations of acute/ subacute brucellosis 
• Swinging pyrexia (up to 40°C-41 0c), with rigors and 
drenching sweats 
• Arthralgia / arthritis, usually monoarticular, in larger joints (hip, 
knee, shoulder, ankle, etc.), resolving in under 6 weeks 
• Low back pain. Sciatica is common (from compression by 
numerous newly-formed osteophytes, or from sacro-iliitis) 
• Headache, insomnia, irritability, occasional depression 
• Small, firm splenomegaly and hepatomegaly; possible discrete 
symmetrical lymphadenopathy, especially in children 
• Leucopenia, with relative lymphocytosis 
started immediately. However, in most patients 
(especially those with B. abortus infections) , the 
acute illness is self-limited after 2- 3 weeks. 
Sub9.cute brucellosis may follow within the first 
three months after the acute illness; but some-
times there is no acute phase , and the illness has 
an insidious onset. The patient develops charac-
teristic recurring waves of pyrexia (often most 
marked in the evening), each showing a step-like 
rise towards a plateau, then a gradual fall over a 
2-week period : hence the term, undulant fever. 
It is not known whether these exacerbations are 
due to recurrent bacteraemias, or to release of 
brucella toxin from lesions. 
The fever is accompanied by severe malaise 
and fatigue and sometimes by manifestations of 
specific organ involvement (including bones, 
joints and meninges; see below, page 87). The 
patient remains well between attacks (which 
may recur over many month s), and most 
patients eventually recover spontaneously. 
Localized disease: bacteraemia occurs in brucel-
losis, and occasionally the disease may present 
insidiously with evidence of localized infection 
in specific organs, notably bones and joints 
(Figure 2). 
Chronic brucellosis: in · a few patients, symp-
toms recur for prolonged periods. Usually, their 
temperature is normal (though it might be 
slightly elevated in the evenings), and the main 
symptoms are recurrent headaches, malaise, 
anorexia , wasting, cough and sweating, mim-
icking early pulmonary tuberculosis. Slight, 
firm splenomegaly or hepatomegaly may occur, 
and less commonly discrete, symmetrical lym-
phadenopathy, especially in children. These 
patients may easily become anxious and 
depressed , especially as the paucity of signs may 
lead to their being labelled neurotic by their 
doctors . 
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Course and prognosis 
In the pre-tetracycline era, brucellosis was asso-
ciated with considerable disability from fre-
quent relapses and complications, lasting many 
months; but the mortality was low (under 5%), 
and limited to the septicaemic types. The gravity 
of the disease varies with the species of Brucella 
responsible. B. melitensis infections are the most 
severe and also have the greatest tendency to 
chronicity, whereas B. abortus and B. suis 
infections are generally milder. B. suis infection 
is more often complicated by suppurative bone 
and visceral lesions . As the result of tetracycline 
therapy, mortality is now negligible and the 
course and complications are usually controlled 
within a few days or weeks. 
Diagnosis 
Brucellosis should be suspected in any patient 
with prolonged pyrexia , musculoskeletal pains 
and a slightly enlarged finn spleen, especially if 
there is a history of consumption of raw milk or 
milk products, or occupational exposure to 
infected animals or their secretions or excre-
tions . Identification of leucopenia reduces the 
number of possible clinical alternatives. How-
ever, for a definite diagnosis , the presence of 
Brucella must be confirmed, either directly or 
ind irectly. 
Culture: attempts should be made to isolate the 
organism from three or more blood cultures, 
taken into special culture medium (the labora-
tory should be notified beforehand). The cul-
tures are best taken on several successive days, 
during the early evening rise in temperature. If 
kept for 6 weeks, up to 80% of cultures will be 
positive in acute cases. In chronic cases, cultures 
of the following may be useful: 
• bone marrow 
• urine 
• exudates 
• aspirates 
• biopsy specimens. 
Serological tests can confirm the presence of 
specific antibodies within 2 days and are there-
fore widely used. They include the routine 
standard agglutination test (SAT), on the blood 
serum (and also on any exudates, e.g. joint 
effusions, abscesses, or body fluids such as CSF 
in meningitis, etc). SAT is usually the early 
method of diagnosis (preferably later confirmed 
by isolation of Brucella on culture). A titre of 
~80 is diagnostic. If lower titres, or negative 
results are obtained in a patient in whom brucel-
losis is suspected clinically, SAT should be 
repeated at intervals (of about 5 days), to look 
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Effects of localized Brucella infection 
2 
Location 
Bones and 
joints 
Heart 
Respiratory 
tract 
Genitourinary 
tract 
Liver 
Nervous system 
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Clinical features 
Chronic osteitis, osteoperiostitis, osteomyelitis, with late 'cold ' 
abscess formation in any part of skeleton 
Spondylitis: usually in lumbo-dorsal vertebral body or margin, 
occasionally in a disc and adjacent vertebrae - radiograph reveals 
a rarefied focus, circumscribed by a denser proliferative process 
and excessive new-osteophyte formation , with 'vertebral bridging ' 
Onset occurs months after defervescence, mostly in elderly men 
- a paravertebral abscess may form - heals spontaneously in 
3-12 months (weeks with tetracycline) 
Subacute arthritis: common, usually monoarticular in a larger joint 
(e.g. knee). Exudate is lymphocytic - Brucella and agglutinins are 
present; resolves in under 6 weeks 
Acute or subacute ulcerative endocarditis (usually affects aortic valve, 
even if previously normal) 
Bronchopneumonia 
Pleurisy, usually dry and fleeting . Empyema is very rare 
Epididymo-orchitis, in about 5% of males; usually late, unilateral , 
quickly resolving 
Granulomatous renal disease 
Granulomatous hepatitis with jaundice (uncommon) 
Hepatolienal syndrome very uncommon 
Meningitis; (but meningism is more common) 
acute or subacute meningitis syndrome during febrile stage; 
CSF is lymphocytic - Brucella and agglutinins present 
Tardive meningo-encephalitis, occurs months after defervescence, 
sudden or insidious onset, usually ending in recovery 
Compression myelitis or myelopathy: 
cord compression, usually by subdural osteomyelitic abscess of the 
dorsal spine. Onset is insidious, months after defervescence~clears 
spontaneously, after many months (weeks with tetracycline) 
Sciatica from compression-radiculitis by vertebral or sacro-iliac 
osteophytes or inflammatory disease 
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for a rise in titre . If the results are persistently 
negative, other serological tests are required to 
reveal (or exclude), possible non-agglutinating 
IgG antibodies. 
Serology, at different stages of disease, 
reflects the pattern of immunological response 
to infection. Both IgM and IgG antibodies 
appear in acute brucellosis (or acute exacerba-
tions). IgM peaks in a few weeks, but may 
persist after recovery; whereas IgG rises slowly, 
peaking in about a year, but eventually disap-
pears after recovery. Thus persistence of specific 
IgG points to active infection. 
Most supplementary tests depend on identify-
ing IgG, and are therefore occasionally useful in 
diagnosing chronic brucellosis. However, it 
must be remembered that in chronic disease the 
results of serological tests are much more diffi-
cult to interpret and may be impossible if 
occupational exposure is continuous (e.g. vete-
rinary surgeons). The tests employed include 
2-mercaptoethanol (2-ME) agglutination test, 
the anti-human globulin (AHG) test and the 
complement fixation test (CF). In general , the 
most useful test is serum anti-brucella immuno-
globulin (IgM, IgG, IgA) estimation by 
radioimmunoassay (RIA), or enzyme-linked 
immunosorbent assay (ELISA). The total 
amount of immunoglobulin indicates the pres-
ence (or absence), of brucellosis, whereas the 
relative titres indicate the disease stage. Thus, in 
acute disease, the titre of IgM is greater than 
that of IgG or IgA, while in chronic disease IgG 
or IgA titres exceed those of IgM. 
Treatment 
In the treatment of brucellosis , the proven 
antibiotic of choice is tetracycline (or its deriva-
tives), usually given orally, 2-3 g/ day in 4- 6 
divided doses, for about 3 weeks. Parenteral 
tetracycline is seldom needed. (Adequate 
amounts of vitamin B-complex, a liberal diet 
and initial bed rest are also recommended.) For 
children the dose is 50 mg/ kg/ day; but the 
significant risk of teeth-staining should be borne 
in mind; the risks of the disease, both in preg-
nancy and in children, usually outweigh this. 
The available alternatives are still unreliable. 
Defervescence occurs within 4--5 days. Load-
ing doses should be avoided, as they are more 
likely to lead to a severe Jarisch-Herxheimer 
reaction. In such a severe reaction, cortico-
steroid therapy may be life-saving. Relapses 
seldom occur, and usually respond to repeat 
courses of tetracycline. 
In exceptional cases, for example, repeated 
relapses in spite of treatment, or acute or sub-
acute endocarditis, tetracycline treatment can 
be supplemented with streptomycin, \ g/ day 
i.m. , or gentamicin, 6 mg/ kg i.m. or i.v. for the 
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first 2- 3 weeks of a 6-week course. Co-
trimoxazole, 2- 3 x 400/ 80 mg tablets b.d. for 
\- 2 months, has been used as an alternative 
therapy for brucellosis, but is less effective than 
tetracycline. 
Prevention 
The following precautions will minimize the risk 
of brucellosis infection. 
• Pasteurize or boil all milk for human 
consumption. 
• Maintain scrupulous hygiene and wear pro-
tective clothing when handling potentially-
infected animals . 
• Vaccinate young animals. 
• Screen animals for Brucella infection and 
slaughter any animal with positive reactions on 
testing. 0 
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